AeroLeads people directory · profile
Jonathan Northrup Email & Phone Number
CEO, CoFounder, Board Member
at
Stingray Therapeutics
1 work email found
@iteriontx.com
6 phones found area 317
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
CEO, CoFounder, Board Member
Location
Dallas, Texas, United States
Who is Jonathan Northrup? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Jonathan Northrup is listed as CEO, CoFounder, Board Member at Stingray Therapeutics, based in Dallas, Texas, United States. AeroLeads shows a work email signal at iteriontx.com, phone signal with area code 317, and a matched LinkedIn profile for Jonathan Northrup.
Jonathan Northrup previously worked as Board Member and Advisor, Vasculonics at Vasculonics and Board Member at Iterion Therapeutics. Jonathan Northrup holds Mba, Finance, Accounting, Marketing from The Wharton School.
Company email context
Email format at Stingray Therapeutics
This section adds company-level context without repeating Jonathan Northrup's masked contact details.
*@iteriontx.com
68% confidence
AeroLeads found 1 current-domain work email signal for Jonathan Northrup. Compare company email patterns before reaching out.
Profile bio
About Jonathan Northrup
2018-Current: CEO & Cofounder Stingray Therapeutics, Immune Oncology - developing the inhibitor of the direct negative, cancer upregulated protein to block innate immunity2018-Current: Board Member & Co-founder - Iterion Therapeutics (Beta Cat Pharmaceuticals) - first safe & effective nuclear beta catenin inhibitor2010-June 2018 CEO & Founder2018-Current: Chair - Far Biotech, next level quantum design for in silico drug discovery across 50 billion possible compounds and scaffold hopping2019-Current: Advisor - Cell Source (CLCS) Immune tolerance for safer (no immune suppression) and more effective (higher cures with CAR-T) cancer treatment and organ transplantation2015-June 2020 Chair & Co-founder - Salarius Pharmaceuticals (SLRX-Nasdaq) Epigenetic modulation important for innate immune oncology and synthetic lethality in SWI/SNF mutations, orphan indication in teenage sarcomas2011-2015 CEO & Chair, Salarius2007-2010 COO, Jubilant InnovationA drug development/venture capital company in Bangalore, India2004-2006 Founder&CEO, Horizon Biotechnologiespharmaceutical R&D services from China,Korea and India. 2004-ELI Lilly; retired after 28 years2002-2004 Corporate Strategy and Business Development, SVP, Strategy and MarketingMarketing group that supports all bus dev added to responsibilities1999–2002 VP, Corporate Strategy, Strategic Asset Management1998 Internal Medicine Senior Director, Strategy,Business Development & New Product Planning 1995–1997 Corporate Business Development, Director - Lead negotiator in over forty alliances including alliances with Elan, Ligand, Protein Design Labs, Vertex, Roche, Seragen, Cubist, Dura, ILEX Oncology, Onyx, Scios, Roberts and Sibia. 1993–1994 Manager, Corporate Business Development; Built the Lilly cancer business through alliances, JVs, spin outs or build within. 1990–1992 Lilly Chicago South,District Sales Manager#1 in Nation for Axid,15 sales representative district.1989 Marketing Studies Manager-LoVan-Developed the marketing effort to launch Prozac for Obesity1987-88 Market Research Manager, Launched Prozac1986 Marketing Studies Manager-Prozac Axid Humatrope Keftab1985 New Product Planning - Infectious Diseases
Listed skills include Biotechnology, Pharmaceutical Industry, Oncology, Lifesciences, and 46 others.
Current workplace
Jonathan Northrup's current company
Company context helps verify the profile and gives searchers a useful next step.
9 roles · 30 years
Jonathan Northrup work experience
A career timeline built from the work history available for this profile.
Board Member And Advisor, Vasculonics
Current
Vasculonics
Sep 2020 - Present
Ceo, Cofounder, Board Member
CurrentStingray is pioneering the next revolution in immune oncology modulators, with inhibitors of ENPP1, an important regulator of the innate immune system with novel applications for immune oncology and infectious diseases.
Jun 2018 - Present
Board Member
Current
Jun 2018 - Present
Board Member And Cofounder
Current
Jan 2012 - Present
Ceo, Board Member, Cofounder
Beta Cat has small molecules which inhibit beta catenin, an important cancer target that has been notoriously difficult to drug. This key protein at the bottom of the WNT embryonic stem cell pathway is taken over by many cancers to allow them to be resistant to many standards of care in oncology - including chemo-therapies, targeted therapies and even the.
Mar 2011 - Jun 2018
Coo
Jubilant Innovation
Founding head of venturing group for Jubilant Life Sciences, a large Indian contract research company doing CMC, discovery collaborations and clinical research. Jubilant Innovation in licensed translational drug development molecules in a codevelopment motiff and did the translational activities within Jubilant.
Jan 2007 - Mar 2011
Ceo & Founder
Horizon Biotechnologies
Run a consultancy company that provides pharmaceutical services done in China, India and Korea to American Pharmaceutical and Biotechnology companies. Represent Chinese, Korean and Indian Companies technology for Business Development and licensing deals for USA and European markets
2004 - 2006
~2 yrs
Vp, Business Development & Strategy
1996 - 2004
~8 yrs
4 education records
Jonathan Northrup education
Mba, Finance, Accounting, Marketing
The Wharton School
Ba Economics, Economics
Northwestern University
Bachelor Of Arts - Ba, Economics
Northwestern University
Bachelor Of Arts (B.A.), Economics
Northwestern University
FAQ
Frequently asked questions about Jonathan Northrup
Quick answers generated from the profile data available on this page.
What company does Jonathan Northrup work for?
Jonathan Northrup works for Stingray Therapeutics.
What is Jonathan Northrup's role at Stingray Therapeutics?
Jonathan Northrup is listed as CEO, CoFounder, Board Member at Stingray Therapeutics.
What is Jonathan Northrup's email address?
AeroLeads has found 1 work email signal at @iteriontx.com for Jonathan Northrup at Stingray Therapeutics.
What is Jonathan Northrup's phone number?
AeroLeads has found 6 phone signal(s) with area code 317 for Jonathan Northrup at Stingray Therapeutics.
Where is Jonathan Northrup based?
Jonathan Northrup is based in Dallas, Texas, United States while working with Stingray Therapeutics.
What companies has Jonathan Northrup worked for?
Jonathan Northrup has worked for Stingray Therapeutics, Vasculonics, Iterion Therapeutics, Salarius Pharmaceuticals, and Beta Cat Pharmaceuticals.
How can I contact Jonathan Northrup?
You can use AeroLeads to view verified contact signals for Jonathan Northrup at Stingray Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Jonathan Northrup attend?
Jonathan Northrup holds Mba, Finance, Accounting, Marketing from The Wharton School.
What skills is Jonathan Northrup known for?
Jonathan Northrup is listed with skills including Biotechnology, Pharmaceutical Industry, Oncology, Lifesciences, Clinical Development, Drug Development, Strategy, and Drug Discovery.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial